Announcements Trials
Browse Landscape

Phase

Phase 2 5

Status

Unknown 2Terminated 1Recruiting 1Completed 1

Sponsor Class

OTHER 3NIH 2

Study Type

Interventional 5

Sponsor

Cancer Type

Gastrointestinal 106Head & Neck 11Thoracic 7Breast 7Genitourinary 6Gynecologic 5Tumor-Agnostic 4Sarcoma 1Other solid neoplasm 1Endocrine 1CNS 1

Conditions

Ovarian Neoplasms 4Fallopian Tube Neoplasms 2Uterine Cervical Neoplasms 1Recurrence 1Neoplasm Metastasis 1Endometrial Neoplasms 1Carcinoma, Ovarian Epithelial 1

Interventions

Paclitaxel 233Carboplatin 217Bevacizumab 139Cisplatin 136pembrolizumab 89Gemcitabine 69olaparib 54Docetaxel 47Topotecan 44Radiotherapy 43liposomal doxorubicin 41Taxes 41niraparib 38Cyclophosphamide 36Doxorubicin 30Drug Therapy 29Letrozole 28Nivolumab 27Magnetic Resonance Spectroscopy 25Immunoglobulin G 25Disulfides 24Oxaliplatin 23Albumin-Bound Paclitaxel 23durvalumab 22apatinib 21Etoposide 21Brachytherapy 21lenvatinib 20camrelizumab 20Specimen Handling 20

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Phase 2 × Panitumumab × Gynecologic × Clear all
NCT05564377 2026-06-02

Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial

National Cancer Institute (NCI)

Phase 2 Recruiting
2,900 enrolled
Gynecologic

Fallopian Tube Neoplasms, Neoplasm Metastasis, Ovarian Neoplasms, Endometrial Neoplasms

NCT01296035 2015-08-25

PanGem

Women and Infants Hospital of Rhode Island

Phase 2 Terminated
8 enrolled 6 charts
Gynecologic

Fallopian Tube Neoplasms, Ovarian Neoplasms

NCT01388621 2013-08-20

PROVE

WiSP Wissenschaftlicher Service Pharma GmbH

Phase 2 Unknown
140 enrolled
Gynecologic

Ovarian Neoplasms, Recurrence

NCT00861120 2012-10-26

PaLiDo

Vejle Hospital

Phase 2 Completed
33 enrolled
Gynecologic

Carcinoma, Ovarian Epithelial, Ovarian Neoplasms

NCT01158248 2010-07-09

Panitumumab, Cisplatin, and Pelvic Radiation Therapy in Treating Patients With Stage IB, Stage II, or Stage III Cervical Cancer

National Cancer Institute (NCI)

Phase 2 Unknown
50 enrolled
Gynecologic

Uterine Cervical Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡